# Supplemental Oxygen in Pulmonary Embolism (SO-PE)

> **NCT05891886** · EARLY_PHASE1 · RECRUITING · sponsor: **Massachusetts General Hospital** · enrollment: 80 (estimated)

## Conditions studied

- Pulmonary Embolism
- Venous Thromboembolism
- Metabolomics
- Oxygen Inhalation Therapy

## Interventions

- **DRUG:** Oxygen Therapy
- **DEVICE:** Non-rebreather mask

## Key facts

- **NCT ID:** NCT05891886
- **Lead sponsor:** Massachusetts General Hospital
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-10-01
- **Primary completion:** 2027-06-30
- **Final completion:** 2027-06-30
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2025-06-15

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05891886

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05891886, "Supplemental Oxygen in Pulmonary Embolism (SO-PE)". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT05891886. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*